Integration of Activation by Hypoxia and Inhibition Resistance of Tumor Cells to Apoptosis for Precise and Augmented Photodynamic Therapy
Authors:
- 25 June 2023
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 12 (25) , e2300503
Abstract
Photodynamic therapy (PDT) uses photosensitizers to convert oxygen (O2) to reactive oxygen species (ROS) under irradiation to induce DNA damage and kill cancer cells. However, the effect of PDT is usually alleviated by apoptosis resistance mechanism of tumor living cells. MTH1 enzyme is known to be such an apoptosis‐resistance enzyme which is over expressed as a scavenger to repair the damaged DNA. In this work, a hypoxia‐activated nanosystem FTPA, which can be degraded to release the encapsulated PDT photosensitizer 4‐DCF‐MPYM and an inhibitor TH588 is proposed. The inhibitor TH588 can inhibit the DNA repair process by reducing the activity of MTH1 enzyme, and achieve the purpose of amplifying the therapeutic effect of PDT. This work demonstrates that a precise and augmented tumor PDT is achieved by integration of hypoxia‐activation and inhibition resistance of tumor cells to apoptosis.Keywords
Funding Information
- National Natural Science Foundation of China (21877011)
- Fundamental Research Funds for the Central Universities (DUT22YG115)
This publication has 39 references indexed in Scilit:
- ROS and the DNA damage response in cancerRedox Biology, 2019
- “Turn‐On” Activatable AIE Dots for Tumor Hypoxia ImagingChemistry – A European Journal, 2019
- Near-Infrared Light-Initiated Molecular Superoxide Radical Generator: Rejuvenating Photodynamic Therapy against Hypoxic TumorsJournal of the American Chemical Society, 2018
- A FRET chemosensor for hypochlorite with large Stokes shifts and long-lifetime emissionsSensors and Actuators B: Chemical, 2018
- Dual‐Stage Light Amplified Photodynamic Therapy against Hypoxic Tumor Based on an O2 Self‐Sufficient NanoplatformSmall, 2017
- Potent and Selective Inhibitors of MTH1 Probe Its Role in Cancer Cell SurvivalJournal of Medicinal Chemistry, 2016
- Development and validation of method for TH588 and TH287, potent MTH1 inhibitors and new anti-cancer agents, for pharmacokinetic studies in mice plasmaJournal of Pharmaceutical and Biomedical Analysis, 2015
- MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP poolNature, 2014
- Highly Discriminating Photorelease of Anticancer Drugs Based on Hypoxia Activatable Phototrigger Conjugated Chitosan NanoparticlesAdvanced Materials, 2013
- Mitochondrial Membrane Potential in Living CellsAnnual Review of Cell Biology, 1988